tvrgrvJfbhh97341 tvrgrvJfbhh97341 15-03-2024 Medicine contestada In a phase 2 clinical trial of 79 patients with stage ii-iv resectable cscc, what pathologic complete response rate was achieved with the use of neoadjuvant cemiplimab?